These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14688011)

  • 1. inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
    Schmidt HH; Pirc-Danoewinata H; Linkesch W; Strunk D; Wieser R
    Haematologica; 2003 Dec; 88(12):ECR38. PubMed ID: 14688011
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
    Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
    Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
    Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
    Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].
    Calderón-Cabrera C; Falantes JF; Bernal R; Pérez-Simón JA
    Med Clin (Barc); 2015 Sep; 145(5):224-6. PubMed ID: 25190583
    [No Abstract]   [Full Text] [Related]  

  • 5. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
    Haferlach T; Schoch C
    Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute minimally differentiated myeloid leukemia (M0) with inv(3)(q21q26).
    Fujisawa S; Tanabe J; Harano H; Kanamori H; Motomura S; Mohri H; Ishigatsubo Y
    Leuk Lymphoma; 1999 Nov; 35(5-6):627-30. PubMed ID: 10609803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
    Chang H; Nayar R; Li D; Sutherland DR
    Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
    Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
    Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
    Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia.
    Wieser R; Lechner K; Valent P; Fonatsch C
    Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
    Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
    Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inversion of chromosome 11 inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: identification of a P1 clone spanning the 11q22 breakpoint.
    Kobayashi H; Arai Y; Hosoda F; Maseki N; Hayashi Y; Eguchi H; Ohki M; Kaneko Y
    Genes Chromosomes Cancer; 1997 Jul; 19(3):150-5. PubMed ID: 9218995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia.
    Wieser R; Schreiner U; Wollenberg B; Neubauer A; Fonatsch C; Rieder H
    Haematologica; 2001 Feb; 86(2):214-5. PubMed ID: 11224497
    [No Abstract]   [Full Text] [Related]  

  • 15. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
    Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
    Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of inv (16) in acute myelomonocytic leukemia by interphase fluorescence in situ hybridization].
    Li J; Pan J; Wu Y; Guo Y; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):30-2. PubMed ID: 12015086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies.
    Wieser R; Schreiner U; Pirc-Danoewinata H; Aytekin M; Schmidt HH; Rieder H; Fonatsch C
    Genes Chromosomes Cancer; 2001 Dec; 32(4):373-80. PubMed ID: 11746978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.